Anixa Biosciences Ownership | Who Owns Anixa Biosciences?

Anixa Biosciences Ownership Summary

Anixa Biosciences is owned by 10.51% institutional investors, 5.38% insiders, and 84.11% retail investors. Vanguard group is the largest institutional shareholder, holding 4.50% of ANIX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.88% of its assets in Anixa Biosciences shares.

ANIX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Anixa Biosciences	10.51%	5.38%	84.11%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.80%	11.85%	52.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	1.46M	4.50%	$4.55M
Laird norton trust company	566.33K	1.70%	$1.46M
Ubs group	551.64K	1.66%	$1.42M
D.a. davidson	539.27K	1.62%	$1.39M
Geode capital management	364.73K	1.10%	$941.44K
Bank of america corp /de/	216.91K	0.68%	$479.38K
Vanguard fiduciary trust	191.07K	0.57%	$492.97K
Marshall wace, llp	173.18K	0.52%	$446.80K
Blackrock funding, inc. /de	170.10K	0.51%	$438.87K
Blackrock	160.42K	0.50%	$354.52K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Prosperity wealth management	41.80K	0.05%	$137.94K
Laird norton trust company	566.33K	0.03%	$1.46M
Westside investment management	47.00K	0.02%	$121.26K
Tyler-stone wealth management	42.02K	0.02%	$97.48K
Lifepro asset management	10.76K	0.02%	$23.78K
Gsa capital partners llp	98.84K	0.02%	$255.00K
Concorde asset management	12.00K	0.01%	$37.44K
D.a. davidson	539.27K	0.01%	$1.39M
Gemmer asset management	35.00K	0.01%	$90.30K
Catalyst funds management pty	12.30K	0.01%	$31.73K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard fiduciary trust	191.07K	0.00%	191.07K
Marshall wace, llp	173.18K	0.00%	132.62K
Bank of america corp /de/	216.91K	-	100.00K
Ubs group	551.64K	0.00%	92.56K
Vanguard group	1.46M	0.00%	37.23K

Top Sellers

Holder	Shares	% Assets	Change
Mission wealth management, lp	-	-	-206.90K
Susquehanna group, llp	99.47K	-	-152.61K
Long focus capital management	-	-	-147.36K
683 capital management	-	-	-113.64K
Exoduspoint capital management, lp	-	-	-93.93K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	191.07K	0.00%	191.07K	$492.97K
Vontobel	30.00K	0.00%	30.00K	$77.40K
Segall bryant & hamill	17.40K	0.00%	17.40K	$51.16K
Two sigma investments, lp	14.49K	-	14.49K	$37.39K
Catalyst funds management pty	12.30K	0.01%	12.30K	$31.73K

Sold Out

Holder	Change
Citigroup	-1.00
Barclays	-9.00
Barrett & company	-80.00
Fmr	-250.00
Hurley capital	-314.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	38	-46.48%	3,493,076	-38.24%	10	3.46%	16	-46.67%	3	-78.57%
Dec 31, 2025	48	-28.36%	4,245,881	-21.80%	13	4.68%	18	-30.77%	8	-
Sep 30, 2025	63	-5.97%	5,412,528	1.19%	16	6.04%	24	9.09%	7	-46.15%
Jun 30, 2025	66	11.86%	5,307,306	-5.33%	16	5.44%	22	15.79%	13	85.71%
Mar 31, 2025	59	-1.67%	5,605,891	-4.05%	17	5.19%	19	-5.00%	7	-22.22%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	927.84K	2.88%	-
Vanguard Total Stock Mkt Idx Inv	936.93K	2.79%	-
Vanguard Institutional Extnd Mkt Idx Tr	355.16K	1.06%	16.15K
Fidelity Extended Market Index	170.11K	0.51%	5.47K
Extended Equity Market Fund E	83.65K	0.25%	-
Blackrock Extended Mkt Fund CF	83.65K	0.25%	-
Extended Equity Market Fund B	83.65K	0.25%	-
iShares Micro-Cap ETF	80.37K	0.24%	-
BlackRock Extended Equity Market K	72.90K	0.23%	-31.00
Extended Equity Market Fund K	71.22K	0.21%	-522.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 12, 2026	KUMAR AMIT	Chief Executive Officer	Buy	$52.50K
Jan 28, 2026	Baskies Arnold M	-	Buy	$30.40K
Jul 31, 2025	Titterton Lewis H jr	-	Buy	$30.80K
Jul 30, 2025	KUMAR AMIT	Chief Executive Officer	Buy	$15.80K
Jul 18, 2025	Baskies Arnold M	-	Buy	$16.95K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	1	-
2025 Q4	-	-
2025 Q3	5	-
2025 Q2	1	-
2025 Q1	8	-

ANIX Ownership FAQ

Who Owns Anixa Biosciences?

Anixa Biosciences shareholders are primarily institutional investors at 10.51%, followed by 5.38% insiders and 84.11% retail investors. The average institutional ownership in Anixa Biosciences's industry, Biotech Stocks , is 35.80%, which Anixa Biosciences falls below.

Who owns the most shares of Anixa Biosciences?

Anixa Biosciences’s largest shareholders are Vanguard group (1.46M shares, 4.50%), Laird norton trust company (566.33K shares, 1.70%), and Ubs group (551.64K shares, 1.66%). Together, they hold 7.86% of Anixa Biosciences’s total shares outstanding.

Does Blackrock own Anixa Biosciences?

Yes, BlackRock owns 0.50% of Anixa Biosciences, totaling 160.42K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 354.52K$. In the last quarter, BlackRock increased its holdings by 5.75K shares, a 3.72% change.

Who is Anixa Biosciences’s biggest shareholder by percentage of total assets invested?

Prosperity wealth management is Anixa Biosciences’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 41.8K Anixa Biosciences shares, valued at 137.94K$.

Who is the top mutual fund holder of Anixa Biosciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anixa Biosciences shares, with 2.88% of its total shares outstanding invested in 927.84K Anixa Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools